Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
Location status: Recruiting
NCT Number: NCT05025774
This study aims to more accurately assess cardiac function, ventilation and exercise capacity in a non-invasive fashion, and to better characterize exercise intolerance in the setting of three populations of individuals with chronic diseases of childhood (acute lymphoblastic leukemia (ALL), chronic lung disease (CLD) of prematurity, and post-heart transplant (HT))
Interested in participating?
Request Info8 year–25 year
All sexes
Observational
Minneapolis, Minnesota, 55455, United States
Location status: Recruiting
Physical activity in childhood is an integral part of maintaining health and quality of life. Children who participate in routine physical activity are more likely to maintain a healthy body weight and are less likely to have heart disease, type 2 diabetes and high blood pressure as adults. Children with chronic disease are often limited from full participation in exercise for various reasons -perceived physical limitations, either from the patient and family or from their medical provider, or because of symptoms which cause exercise to feel uncomfortable. As the number of children living and aging with chronic disease continues to grow, the researchers are hoping to expand the current exercise testing capabilities for both clinical care and research in order to (i) provide data to permit formulation of evidence-based guidelines for exercise in chronic childhood disease; (ii) improve understanding of limitations to exercise in this growing population; (iii) learn long-term implications of chronic childhood disease as these individuals enter adulthood.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participant Reported Physical Activity and Outcomes (completed via REDCap or on paper)
Time frame: 3-4 hours during the onetime study visit day
Maximal cardiopulmonary exercise testing (CPX) will be completed on cycle ergometer to determine peak oxygen uptake, a measure of cardiorespiratory fitness
Time frame: 3-4 hours during the onetime study visit day
Cardiac output is measured using C2H2 open-circuit breathing technique: a mass spectrometer medical gas analyzer will measure gas concentration continuously, yielding serial Stroke Volume measurements during incremental exercise. Cardiac output is the product of heart rate and stroke volume
Time frame: 3-4 hours during the onetime study visit day
The proportion of expiratory flow limitation (EFL) during exercise while tracking dyspnea and perceived exertion
Time frame: 3-4 hours during the onetime study visit day
Logistic regression will be used to understand associations between cardiac function and patient reported outcomes of perceived fitness
Contact information is provided by the study sponsor or research team.
Char Napurski, MPH, CCRP
CONTACT
Pianosi Paolo, MD
CONTACT
Masonic Cancer Center, University of Minnesota
Other
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant Bronchopulmonary Dysplasia (BPD, Also Known as Chronic Lung Disease of Prematurity) Through Exercise (FLASHLITE)
Acronym: FLASHLITE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06326957
Asthma, Bronchial Diseases
London, United Kingdom
View Trial DetailsNCT06174207
Asthma, Bronchial Diseases
Winterthur, Canton of Zurich, Switzerland
View Trial DetailsNCT06304207
Bronchial Diseases, Bronchiectasis
Charlestown, Massachusetts, United States
View Trial DetailsNCT06112730
Chronic Disease, Chronic Lung Disease
New Taipei City, Taiwan
View Trial Details